File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Editorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end

TitleEditorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end
Authors
Mak, Lung‐Yi
Issue Date26-Oct-2023
PublisherWiley
Citation
Alimentary Pharmacology and Therapeutics, 2023, v. 58, n. 10, p. 1103-1104 How to Cite?
DOI: http://dx.doi.org/10.1111/apt.17690
Persistent Identifierhttp://hdl.handle.net/10722/339115
ISSN
0269-2813
2023 Impact Factor: 6.6
2023 SCImago Journal Rankings: 2.794
ISI Accession Number ID
WOS:001089580000012

 

DC FieldValueLanguage
dc.contributor.authorMak, Lung‐Yi-
dc.date.accessioned2024-03-11T10:34:00Z-
dc.date.available2024-03-11T10:34:00Z-
dc.date.issued2023-10-26-
dc.identifier.citationAlimentary Pharmacology and Therapeutics, 2023, v. 58, n. 10, p. 1103-1104-
dc.identifier.issn0269-2813-
dc.identifier.urihttp://hdl.handle.net/10722/339115-
dc.languageeng-
dc.publisherWiley-
dc.relation.ispartofAlimentary Pharmacology and Therapeutics-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleEditorial: HBsAg seroclearance after pegylated interferon treatment—The beginning of the end-
dc.typeArticle-
dc.identifier.doi10.1111/apt.17690-
dc.identifier.scopuseid_2-s2.0-85175087001-
dc.identifier.volume58-
dc.identifier.issue10-
dc.identifier.spage1103-
dc.identifier.epage1104-
dc.identifier.eissn1365-2036-
dc.identifier.isiWOS:001089580000012-
dc.identifier.issnl0269-2813-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats